NORGES BANK - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$311,000
-95.5%
25,000
-88.8%
0.00%
-100.0%
Q3 2021$6,950,000
+870.7%
222,400
+789.6%
0.00%
Q2 2021$716,000
-33.9%
25,0000.0%0.00%
Q1 2021$1,083,000
-24.3%
25,000
+25.0%
0.00%
Q4 2020$1,431,000
+137.3%
20,0000.0%0.00%
Q3 2020$603,00020,0000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$287,436,0002.91%
Baker Brothers Advisors 10,123,824$289,845,0001.27%
Logos Global Management LP 400,000$11,452,0000.96%
Rock Springs Capital Management LP 382,359$10,947,0000.22%
HHLR ADVISORS, LTD. 583,333$16,701,0000.17%
Virtus ETF Advisers LLC 6,622$190,0000.08%
Jump Financial, LLC 13,700$392,0000.04%
ARS Investment Partners, LLC 7,400$212,0000.02%
FEDERATED HERMES, INC. 336,100$9,623,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,287,735$36,867,853,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders